BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8359812)

  • 1. Risk of ovarian cancer and genetic relationship to other cancers in families.
    Houlston RS; Bourne TH; Collins WP; Whitehead MI; Campbell S; Slack J
    Hum Hered; 1993; 43(2):111-5. PubMed ID: 8359812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggregation of ovarian cancer with breast, ovarian, colorectal, and prostate cancer in first-degree relatives.
    Tung KH; Goodman MT; Wu AH; McDuffie K; Wilkens LR; Nomura AM; Kolonel LN
    Am J Epidemiol; 2004 Apr; 159(8):750-8. PubMed ID: 15051584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer risks in BRCA2 mutation carriers.
    Breast Cancer Linkage Consortium
    J Natl Cancer Inst; 1999 Aug; 91(15):1310-6. PubMed ID: 10433620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial clustering of colon, breast, uterine, and ovarian cancers as assessed by family history.
    Nelson CL; Sellers TA; Rich SS; Potter JD; McGovern PG; Kushi LH
    Genet Epidemiol; 1993; 10(4):235-44. PubMed ID: 8224804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a single BRCA2 mutation on cancer in Iceland.
    Tulinius H; Olafsdottir GH; Sigvaldason H; Arason A; Barkardottir RB; Egilsson V; Ogmundsdottir HM; Tryggvadottir L; Gudlaugsdottir S; Eyfjord JE
    J Med Genet; 2002 Jul; 39(7):457-62. PubMed ID: 12114473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoplastic diseases in families of breast cancer patients.
    Tulinius H; Olafsdottir GH; Sigvaldason H; Tryggvadottir L; Bjarnadottir K
    J Med Genet; 1994 Aug; 31(8):618-21. PubMed ID: 7815419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial effects of prostate and other cancers on lifetime breast cancer risk.
    Anderson DE; Badzioch MD
    Breast Cancer Res Treat; 1993 Nov; 28(2):107-13. PubMed ID: 8173063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial risk of cancer shortly after diagnosis of the first familial tumor.
    Bermejo JL; Hemminki K
    J Natl Cancer Inst; 2005 Nov; 97(21):1575-9. PubMed ID: 16264177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
    Leu M; Reilly M; Czene K
    J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial prostate cancer and possible associated malignancies: nation-wide register cohort study in Sweden.
    Damber L; Grönberg H; Damber JE
    Int J Cancer; 1998 Oct; 78(3):293-7. PubMed ID: 9766560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer.
    Tulinius H; Egilsson V; Olafsdóttir GH; Sigvaldason H
    BMJ; 1992 Oct; 305(6858):855-7. PubMed ID: 1422397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based study of the prevalence of family history of cancer: implications for cancer screening and prevention.
    Ramsey SD; Yoon P; Moonesinghe R; Khoury MJ
    Genet Med; 2006 Sep; 8(9):571-5. PubMed ID: 16980813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reported family history of cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Pinsky PF; Kramer BS; Reding D; Buys S;
    Am J Epidemiol; 2003 May; 157(9):792-9. PubMed ID: 12727673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White blood cell DNA methylation and risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO).
    Sturgeon SR; Pilsner JR; Arcaro KF; Ikuma K; Wu H; Kim SM; Chopra-Tandon N; Karpf AR; Ziegler RG; Schairer C; Balasubramanian R; Reckhow DA
    Breast Cancer Res; 2017 Aug; 19(1):94. PubMed ID: 28821281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-based cohort investigations of the risk for malignant tumors in first-degree relatives and wives of men with breast cancer.
    Olsson H; Andersson H; Johansson O; Möller TR; Kristoffersson U; Wenngren E
    Cancer; 1993 Feb; 71(4):1273-8. PubMed ID: 8435804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic epidemiology of breast cancer and associated cancers in high-risk families. I. Segregation analysis.
    Go RC; King MC; Bailey-Wilson J; Elston RC; Lynch HT
    J Natl Cancer Inst; 1983 Sep; 71(3):455-61. PubMed ID: 6577220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of trends in age-adjusted incidence rates for 10 major sites of cancer.
    Sullivan PD; Christine B; Connelly R; Barrett H
    Am J Public Health; 1972 Aug; 62(8):1065-71. PubMed ID: 5046446
    [No Abstract]   [Full Text] [Related]  

  • 18. Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations.
    Lee JS; John EM; McGuire V; Felberg A; Ostrow KL; DiCioccio RA; Li FP; Miron A; West DW; Whittemore AS
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):359-63. PubMed ID: 16492929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of ovarian cancer in women with first-degree relatives with cancer.
    Soegaard M; Frederiksen K; Jensen A; Høgdall E; Høgdall C; Blaakaer J; Ramus SJ; Gayther SA; Kjaer SK
    Acta Obstet Gynecol Scand; 2009; 88(4):449-56. PubMed ID: 19266357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer variation associated with the position of the mutation in the BRCA2 gene.
    Lubinski J; Phelan CM; Ghadirian P; Lynch HT; Garber J; Weber B; Tung N; Horsman D; Isaacs C; Monteiro AN; Sun P; Narod SA
    Fam Cancer; 2004; 3(1):1-10. PubMed ID: 15131399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.